Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
137 Results Found
340B Advocacy Alliance Bulletin - October 31, 2024
AHA releases Regulatory Advisory summarizing CMS final guidance on implementation of the Medicare Drug Price Negotiation Program
340B Advocacy Alliance Bulletin - September 9, 2024
As urged by the AHA and others, J&J tells HRSA it is abandoning proposed 340B rebate plan.
AHA 340B Advocacy Alliance Bulletin - August 28, 2024
If Johnson & Johnson moves forward with its plan to undermine the 340B Drug Pricing Program by unilaterally imposing a rebate model rather than the longstanding upfront discount model, the Health Resources and Services Administration should take “immediate enforcement action,” including assessing civil monetary penalties on Johnson & Johnson for intentionally overcharging 340B hospitals, the AHA said today in a letter to HRSA.
AHA 340B Advocacy Alliance Bulletin - September 24, 2024
The deadline has been extended for representatives to sign onto a letter that urges the Department of Health and Human Services to take action to stop Johnson & Johnson’s plan “to upend more than 30 years of federal law by delaying access to 340B Drug Pricing Program (340B) discounts on pharmaceuticals for certain safety-net hospitals.”
AHA 340B Advocacy Alliance September 3, 2024
The AHA, 340B Health and the American Society of Health-System Pharmacists last week filed an amicus brief in a federal district court in Missouri, defending the state's law protecting 340B pricing for contract pharmacy arrangements.
AHA 340B Advocacy Alliance Bulletin: HRSA Issues Final Warning to J&J on 340B Proposal
The Health Resources and Services Administration today sent a final warning letter to Johnson & Johnson urging the company to inform the agency by Monday, Sept. 30 that it would halt its proposed 340B rebate model scheduled to go into effect next month.
AHA 340B Advocacy Alliance Bulletin - October 8, 2024
The AHA, 340B Health, the Minnesota Hospital Association and American Society of Health-System Pharmacists Oct. 4 filed two amicus briefs in the U.S. District Court for the District of Minnesota, defending the state's law protecting 340B pricing for contract pharmacy arrangements.
AHA 340B Advocacy Alliance Bulletin - October 4, 2024
The Department of Health and Human Services Oct. 2 released final guidance detailing the process for the second cycle of negotiations under the Medicare Drug Price Negotiation Program.
AHA 340B Advocacy Alliance October 1, 2024
A Louisiana district court yesterday upheld a state law prohibiting drug companies from denying Louisiana hospitals 340B discounts for drugs dispensed at community pharmacies.
AHA 340B Advocacy Alliance Bulletin - September 18, 2024
Urge your representatives to sign letter to HHS asking it to take action to protect providers from ‘devastating’ J&J 340B proposal; deadline is Sept. 20.